Andrew D. Dickinson - Feb 6, 2022 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)

Role
Chief Financial Officer
Signature
/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
Stock symbol
GILD
Transactions as of
Feb 6, 2022
Transactions value $
-$49,011
Form type
4
Date filed
2/8/2022, 07:25 PM
Previous filing
Jan 28, 2022
Next filing
Apr 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $0 +1.82K +3.1% $0.00 60.5K Feb 6, 2022 Direct F1
transaction GILD Common Stock Tax liability -$49K -767 -1.27% $63.90 59.7K Feb 6, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1.82K -4.86% 35.6K Feb 6, 2022 Common Stock 1.82K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.